Identification of Patients with Recurrent Epithelial Ovarian Cancer Who Will Benefit from More Than Three Lines of Chemotherapy

PURPOSE: This study aimed to identify patients who would benefit from third and subsequent lines of chemotherapy in recurrent epithelial ovarian cancer (EOC). MATERIALS AND METHODS: Recurrent EOC patients who received third, fourth, or fifth-line palliative chemotherapy were retrospectively analyzed...

Descripción completa

Detalles Bibliográficos
Autores principales: Seol, Aeran, Yim, Ga Won, Chung, Joo Yeon, Kim, Se Ik, Lee, Maria, Kim, Hee Seung, Chung, Hyun Hoon, Kim, Jae-Weon, Park, Noh Hyun, Song, Yong Sang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582485/
https://www.ncbi.nlm.nih.gov/pubmed/34793667
http://dx.doi.org/10.4143/crt.2021.1010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582485/
https://www.ncbi.nlm.nih.gov/pubmed/34793667
http://dx.doi.org/10.4143/crt.2021.1010

Ejemplares similares